Jennifer McNealey

Jennifer Isacoff McNealey is an accomplished finance professional with extensive experience in the biotechnology sector. As the Chief Financial Officer of Abdera Therapeutics since January 2023, Jennifer has previously held significant roles including Chief Financial Officer at Codex DNA, Board Member at Antibe Therapeutics Inc. and Enzon Pharmaceuticals, and Vice President of Investor Relations and Strategy at Calithera Biosciences. Notable achievements include transitioning investor outreach through a successful IPO at Calithera and managing corporate strategy and communications. Jennifer founded Laurient, where focus was on research for biotechnology investments, and has held investment management positions at Paramount Capital and Franklin Templeton Investments. Jennifer holds a Master's degree in Health Care Administration and a Bachelor's degree in Psychology and Gerontology from Cornell University.